Merck To Buy Biotech Co. Millipore For $7.2B

Law360, New York (March 01, 2010, 2:41 PM ET) -- Merck KGaA has agreed to acquire biotechnology company Millipore Corp. for $7.2 billion, a move the German pharmaceutical giant says will bolster its laboratory equipment business.

Under the terms of the deal, announced Sunday, Merck will acquire all outstanding shares of Billerica, Mass.-based Millipore for $107 per share in cash, according to the companies.

The transaction has already received the blessing of boards of directors for both companies, they added.

“This transaction is very attractive to shareholders, customers and employees of both companies,” said Dr. Karl-Ludwig...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required